• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pernix Therapeutics Holdings Inc

+ Add to Watchlist


9.3200 USD 0.1900 2.08%

As of 09:33:10 ET on 12/29/2014.

Snapshot for Pernix Therapeutics Holdings Inc (PTX)

Open: 9.1000 Day's Range: 9.0900 - 9.3200 Volume: 10,340
Previous Close: 9.1300 52wk Range: 2.0500 - 11.6800 1-Yr Rtn: +280.42%

Stock Chart for PTX

No chart data available.
  • PTX:US 9.2200
  • 1D
  • 1M
  • 1Y
Interactive PTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4687
Est. EPS (USD) (12/2014) -0.1600
Est. PEG Ratio -
Market Cap (M USD) 349.60
Shares Outstanding (M) 38.29
30 Day Average Volume 463,776
Price/Book (mrq) 3.9211
Price/Sale (ttm) 3.7402
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 09/08/2001
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTX

Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.

Douglas Drysdale "Doug"Chairman/President/CEOSanjay S PatelChief Financial Officer
Terence S Novak "Terry"Chief Operating OfficerBrian T DorseySenior VP:Pharmaceutical Dev
More Company Profile & Key Executives for PTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil